Newsletters

03.28.23

Recent AI Developments And The Practice Of Law—An Update

There have been many recent artificial intelligence (AI) developments over the past several weeks that impact the practice of law.


03.27.23

FAA Preempts AB 51, Ninth Circuit Holds

The battle over arbitration in California continues, with a divided panel of the Ninth U.S. Circuit Court of Appeals ruling that the Federal Arbitration Act preempts the state’s Assembly Bill 51, a law that prohibits employers from requiring employees to execute an arbitration agreement as a ...


03.27.23

NLRB: Confidentiality, Non-Disparagement Provisions Violate NLRA

Offering an employee a severance agreement that includes confidentiality and non-disparagement provisions runs afoul of Section 8(a)(1) of the National Labor Relations Act (NLRA), a divided National Labor Relations Bureau (NLRB) recently ruled.


03.27.23

California Appellate Panel Defines ‘Willful’ Wage Nonpayment and ‘Good Faith Dispute’

A California appellate panel has weighed in on premium pay in a decision on remand from the state’s highest court, with an employer-friendly result.


03.27.23

SCOTUS Sides With Daily-Rate Employee

Siding with an employee, the U.S. Supreme Court held that a daily-rate employee was entitled to overtime under the Fair Labor Standards Act (FLSA) despite the fact he earned over $200,000 annually.


03.27.23

California Considers New Employment Legislation

With the 2023 California legislative session underway, employers should keep an eye on several employment-related bills already pending.


03.24.23

Executive Summary: Tracking Telehealth Changes State-by-State in Response to COVID-19

As the COVID-19 pandemic continues across the United States, states, payers, and providers are looking for ways to expand access to telehealth services.


03.24.23

Sellers Beware: FTC Proposes Changes to Automatic Renewal Laws

Yesterday, the Federal Trade Commission announced a proposed update to its rules governing automatic renewals.


03.23.23

FDA Announces the Discontinuation of Certain COVID-19-Related Guidance Documents

The United States Food and Drug Administration published a notice in the Federal Register on March 13, 2023, addressing the agency’s various COVID-19-related guidance documents issued by all of the medical product centers.


03.22.23

New Guidance Instructs IDR Entities to Resume All Payment Determinations Under No Surprises Act

As of March 17, certified independent dispute resolution entities may resume IDR payment determinations under the No Surprises Act that were temporarily halted last month due to a Texas court’s decision vacating portions of the final federal regulations implementing the IDR process.